why choose us

First received: March 05, 2024

Clinical Trial: A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Subjects

Study Type: INTERVENTIONAL


Official Title: A First-in-human, Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Brief Summary: The purpose of this first-in-human trial is to investigate the safety, tolerability, and pharmacokinetics of APC148 after intravenous (IV) infusion of single ascending doses in healthy adults.

Read more